Contact Us: 1-518-583-0095 
We’re Hiring… Join Our Team!
A collaborative virtual clinical trial will study the effectiveness of two digital therapeutics. Both digital therapeutics are anticipated to have an impact on mental and physical health when used adjunctively with multidisciplinary oncology care regimens.
Continue readingWatch this PharmaVoice One on One video interview to learn more about the latest in breast cancer research from Dr. Peter Kabos, Director of the Academic Breast Cancer Consortium and Assistant Professor in the Division of Medical Oncology at University of Colorado Cancer Center.
Continue readingThe Exablate Prostate system uses sound waves to ablate, or destroy, targeted tissue in the prostate. The treatment is performed under Magnetic Resonance Imaging (MRI) guidance for high resolution visualization of the patient’s anatomy for precise targeting and real-time temperature monitoring.
Continue readingWatch the PharmaVoice One on One video interview below to learn more about the latest in Thoracic Oncology research from Dr. D. Ross Camidge, Director of the Academic Thoracic Oncology Medical Investigators Consortium and Director of Thoracic Oncology at the University of Colorado.
Continue readingBreast Cancer Awareness Month is a month for promoting breast cancer awareness and the importance of research, early detection, and prevention.
Continue readingSickle Cell Disease is a group of inherited red blood cell disorders that affects hemoglobin, the protein that carries oxygen through the body.
Continue readingWatch the PharmaVoice One on One video interview below to learn more about the latest in Gastrointestinal Cancer research from Dr. Wells Messersmith, Director of the Academic GI Cancer Consortium and Division Head of Medical Oncology at the University of Colorado Cancer Center.
Continue readingCriterium’s Academic Breast Cancer Consortium (ABRCC) is comprised of 15 renowned academic and community sites in North America, conducting translational research in Breast Cancer studies for major pharmaceutical companies who are working on the most current clinical trials for advanced treatments of breast cancer. While 2020 was a year dominated by COVID-19 news and tragedy, breast cancer research and breakthroughs can’t wait for COVID to “go away” – and research in this area continues on full-speed. Our ABRCC researchers reflect on 2020 and look ahead to 2021 with renewed hope.
Continue readingFor November’s Lung Cancer Awareness Month, Heather Smith and Melissa Turner share the stories of their cancer journeys. The women took very different routes to the CU Cancer Center and the world-renowned lung cancer care of Ross Camidge, MD. On this episode of the CU Anschutz 360 podcast, learn why they love everything about Dr. Camidge’s practice, especially the fact that he makes them laugh.
Continue readingFindings from a CHOP/Penn Medicine study could lead to treatment for patients with lung disease, including acute respiratory distress syndrome due to COVID-19.
Continue reading